Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts University of Cincinnati/Cincinnati Children's Hospital, Cincinnati, Ohio Ohio State University, Columbus, Ohio University of Pennsylvania, Philadelphia, Pennsylvania University of Pittsburg, Pittsburgh, Pennsylvania